Cargando…

Characterization of a hepatitis C virus genotype 1 divergent isolate from an HIV-1 coinfected individual in Germany assigned to a new subtype 1o

BACKGROUND: HCV exhibits a high genetic diversity and is classified into 7 genotypes which are further divided into 86 confirmed subtypes. However, there are multiple isolates with unassigned subtypes. We aimed to amplify and characterize the full-length genome sequence of an HCV genotype 1 (HCV-1)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bo, Krüger, Luise, Machnowska, Patrycja, Eshetu, Amare, Gunsenheimer-Bartmeyer, Barbara, Bremer, Viviane, Hauser, Andrea, Bannert, Norbert, Bock, C.-Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399946/ https://www.ncbi.nlm.nih.gov/pubmed/30832687 http://dx.doi.org/10.1186/s12985-019-1135-7

Ejemplares similares

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017–2020
por: Fiebig, Uwe, et al.
Publicado: (2023)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses
por: Hauser, Andrea, et al.
Publicado: (2018)

The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany
por: Pantke, Annemarie, et al.
Publicado: (2022)

National molecular surveillance of recently acquired HIV infections in Germany, 2013 to 2014
por: Hauser, Andrea, et al.
Publicado: (2017)

Factors associated with the informal use of HIV pre‐exposure prophylaxis in Germany: a cross‐sectional study
por: Koppe, Uwe, et al.
Publicado: (2019)

Barriers to using HIV pre-exposure prophylaxis (PrEP) and sexual behaviour after stopping PrEP: a cross-sectional study in Germany
por: Koppe, Uwe, et al.
Publicado: (2021)

HIV, STI and renal function testing frequency and STI history among current users of self-funded HIV pre-exposure prophylaxis, a cross-sectional study, Germany, 2018 and 2019
por: Koppe, Uwe, et al.
Publicado: (2022)

Surveillance of recent HIV infections among newly diagnosed HIV cases in Germany between 2008 and 2014
por: Hofmann, Alexandra, et al.
Publicado: (2017)

High Prevalence and High Incidence of Coinfection with Hepatitis B, Hepatitis C, and Syphilis and Low Rate of Effective Vaccination against Hepatitis B in HIV-Positive Men Who Have Sex with Men with Known Date of HIV Seroconversion in Germany
por: Jansen, Klaus, et al.
Publicado: (2015)

Analysis of transmitted drug resistance and HIV-1 subtypes using dried serum spots of recently HIV-infected individuals in 2013 in Germany
por: Andrea, Hauser, et al.
Publicado: (2014)

Decreased emergence of HIV-1 drug resistance mutations in a cohort of Ugandan women initiating option B+ for PMTCT
por: Machnowska, Patrycja, et al.
Publicado: (2017)

A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones
por: Hanke, Kirsten, et al.
Publicado: (2020)

HIV-Prevalence in Tuberculosis Patients in Germany, 2002–2009: An Estimation Based on HIV and Tuberculosis Surveillance Data
por: Fiebig, Lena, et al.
Publicado: (2012)

Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058
por: van de Vijver, David A M C, et al.
Publicado: (2019)

Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany
por: Nielsen, Stine, et al.
Publicado: (2016)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
por: Valbert, Frederik, et al.
Publicado: (2023)

Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany
por: Schmidt, Daniel, et al.
Publicado: (2022)

580. Key Factors for Treatment Changes Within 1 Year After Starting ART in the German ClinSurv Cohort: Between 2005 and 2014
por: Stecher, Melanie, et al.
Publicado: (2018)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

CD4-cell counts and presence of AIDS in HIV-positive patients entering specialized care—a comparison of migrant groups in the German ClinSurv HIV Cohort Study, 1999–2013
por: Zeitlmann, Nadine, et al.
Publicado: (2016)

Improved Testing of Recent HIV-1 Infections with the BioRad Avidity Assay Compared to the Limiting Antigen Avidity Assay and BED Capture Enzyme Immunoassay: Evaluation Using Reference Sample Panels from the German Seroconverter Cohort
por: Hauser, Andrea, et al.
Publicado: (2014)

Hantavirus–Leptospira coinfections in small mammals from central Germany
por: Jeske, K., et al.
Publicado: (2021)

Unexpected Presence of Blastocystis Subtype 1–3 DNA in Human Vaginal and Sperm Samples Coinfected with Trichomonas vaginalis
por: Villalobos, Guiehdani, et al.
Publicado: (2022)

Questioning the IGF1 receptor’s assigned role in CRC – a case for rehabilitation?
por: Heckl, Steffen M., et al.
Publicado: (2020)

A multidimensional HIV-1 persistence model for clonal expansion and viral rebound in vitro
por: Eshetu, Amare, et al.
Publicado: (2021)

Total Synthesis, Stereochemical Assignment, and Divergent Enantioselective Enzymatic Recognition of Larreatricin
por: Martin, Harry J., et al.
Publicado: (2018)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
por: Meixenberger, Karolin, et al.
Publicado: (2017)

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20 years (1999–2018)
por: Schmidt, Daniel, et al.
Publicado: (2021)

Role of regulatory proteins in HIV-1/HTLV-1 coinfection
por: Edwards, Dustin, et al.
Publicado: (2014)

Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control
por: Korr, Gerit, et al.
Publicado: (2017)

Resonance assignment of the Shank1 PDZ domain
por: Sánta, Anna, et al.
Publicado: (2022)

HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progression
por: Archary, Derseree, et al.
Publicado: (2010)

Dating the time of viral subtype divergence
por: O'Brien, John D, et al.
Publicado: (2008)

Sex-divergent effects of hindbrain GLP-1-producing neuron activation in rats
por: Lopez-Ferreras, Lorena, et al.
Publicado: (2023)

Neurological Aspects of HIV-1/HTLV-1 and HIV-1/HTLV-2 Coinfection
por: Araujo, Abelardo Q.-C.
Publicado: (2020)

Highly variable use of diagnostic methods for sexually transmitted infections-results of a nationwide survey, Germany 2005
por: Gilsdorf, Andreas, et al.
Publicado: (2010)

Backbone Assignment of the MALT1 Paracaspase by Solution NMR
por: Unnerståle, Sofia, et al.
Publicado: (2016)

Coinfection with chytrid genotypes drives divergent infection dynamics reflecting regional distribution patterns
por: Carvalho, Tamilie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_66906nlb7j097mm720hkhf474f